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Introduction
• Patients suffering from inflammatory bowel 
disease (IBD) are at increased risk for 
developing cancer. 
• Adenocarcinomas are the most commonly 
observed tumors of the gastrointestinal tract, 
whereas data on gastrointestinal stromal 
tumor (GIST) in IBD patients is limited. 
• This case report presents the first reported 
case of gastric GIST in a patient with 
Crohn’s disease.
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Conclusions• A 40-year old Caucasian man with a 
history of small bowel Crohn’s disease 
on infliximab develops acute abdominal 
pain, hematochezia, diffuse joint pain.
• Abdominal CT scan shows a 2.5 cm 
exophytic mass in stomach with possible 
liver metastases.
• Endoscopic ultrasound guided biopsy of 
the mass reveals cells positive for 
proteins CD117 and DOG1, confirming 
GIST.
• Patient underwent surgical resection 
without complication and is back to his 
usual state of health.
Fig. 1, 2 Gastric mass on coronal and axial CT imaging
Fig. 3, 4 Endoscopic ultrasound of gastric mass and microscopic examination of GIST
• GIST is a neoplasm that arises from the 
interstitial cells of Cajal in GI smooth muscle. 
• Presence of CD117 and DOG1 proteins in 
neoplasm are highly sensitive and specific 
for GIST. 
• Negative prognostic indicators include high 
mitotic index and location. 
• Mortality per location: omentum/mesentery > 
colon/rectum > small bowel > stomach > 
esophagus.
• Current treatment involves a combination 
surgery and/or Imatinib or other tyrosine 
kinase inhibitors.
This first reported case of gastric GIST 
diagnosed in a patient with Crohn’s disease 
emphasizes that while there exists a well-
known association between IBD and colon 
cancer, other malignancies including GIST 
should be kept in mind when evaluating 
patients with IBD found to have new 
masses on imaging.
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